Breakpoint to Minimum Inhibitory Concentration Quotient: A Critical Metric for Optimizing Antimicrobial Decision-making
Authors:
Open Access
- 1 April 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Datta Meghe Institute of Medical Sciences University
- Vol. 20 (2) , 456-461
Abstract
Antibiotic selection and dosing strategies are fundamentally guided by antibiotic susceptibility, which relies on minimum inhibitory concentration (MIC) values and established clinical breakpoints. Breakpoint to MIC quotient (BMQ) is the ratio of the clinical breakpoint to the MIC of the infecting pathogen and serves as a determinant of the drug’s efficacy margin. A higher BMQ suggests a greater likelihood of treatment success, whereas a lower quotient may indicate borderline efficacy, requiring dose optimization or alternative therapy. This quotient aids in balancing drug selection when various agents exhibit identical susceptibility categorizations but differ in clinical susceptibility breakpoint. BMQ has emerged as a critical parameter in optimizing antimicrobial therapy by integrating pharmacokinetic/pharmacodynamic relationships with bacterial susceptibility profiles. This narrative review aims to explore the concept, significance, challenges, and future prospects of BMQ in guiding antimicrobial therapy.Keywords
This publication has 16 references indexed in Scilit:
- Mutant Prevention Concentration, Frequency of Spontaneous Mutant Selection, and Mutant Selection Window—a New Approach to the In Vitro Determination of the Antimicrobial Potency of CompoundsAntimicrobial Agents and Chemotherapy, 2023
- ICMR’s Antimicrobial Resistance Surveillance system (i-AMRSS): a promising tool for global antimicrobial resistance surveillanceJAC-Antimicrobial Resistance, 2021
- Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on EnterobacteriaceaeInternational Journal of Antimicrobial Agents, 2019
- Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective studyAnnals of Clinical Microbiology and Antimicrobials, 2017
- Antimicrobial Heteroresistance: an Emerging Field in Need of ClarityClinical Microbiology Reviews, 2015
- Protein Binding: Do We Ever Learn?Antimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetics and Pharmacodynamics of Antibacterial AgentsInfectious Disease Clinics of North America, 2009
- A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving BreakpointsInfection, 2009
- WHONET Software for the Surveillance of Antimicrobial SusceptibilityMedical Journal Armed Forces India, 2009
- Setting and Revising Antibacterial Susceptibility BreakpointsClinical Microbiology Reviews, 2007